中文版

NEWS

Title: Fountain Biopharma, Inc. Anti-CεmX, anti-allergy therapeutic monoclonal antibody, FB825 was granted for treatment of Hyperimmunoglobulin E synd ......
2017-10-11
CHO Pharma has announced that the IND application of its new drug CHO-H01 was approved by the USFDA on August 26th, which will soon enter Phase I ......
2017-08-28
Led by Academia Sinica, CHO pharma is a biopharmaceutical company invested by Taiwan's largest biotechnology firm, Diamond Biofund Inc. CHO Pharma's I ......
2017-08-24
Yesterday, Oneness Biotech Co. announced that the multinational phase III clinical trial of ON101, a new drug for diabetic foot ulcer, has been approv ......
2017-07-19
JOIN MICROBIO GROUP

At Microbio group, we encourage people bring new perspectives and utilize professional experiences to our business. We invite you to be part of our innovation-driven team and becoming world’s top leaders in biopharmaceuticals.